Lv41
470 积分 2024-10-11 加入
Navigating CAR-T cells through the solid-tumour microenvironment
4小时前
待确认
Conditionally active T cell engagers for the treatment of solid tumors: rationale and clinical development
2个月前
已完结
An Engineered Soluble Single-Chain TCR Engager for KRAS-G12V Specific Tumor Immunotherapy
2个月前
已完结
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3
6个月前
已完结
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
6个月前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
6个月前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
6个月前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid
6个月前
已完结
Disease diagnostics using machine learning of B cell and T cell receptor sequences
7个月前
已完结
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
7个月前
已完结
皖公网安备34019202002308
